T

Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM

Watchlist Manager
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Watchlist
Price: 3 399.45 INR -0.61%
Market Cap: 1.2T INR
Have any thoughts about
Torrent Pharmaceuticals Ltd?
Write Note

Torrent Pharmaceuticals Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Torrent Pharmaceuticals Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
EPS (Diluted)
â‚ą53
CAGR 3-Years
12%
CAGR 5-Years
26%
CAGR 10-Years
8%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
EPS (Diluted)
â‚ą64
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
EPS (Diluted)
â‚ą55
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
EPS (Diluted)
â‚ą46
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
4%
Lupin Ltd
NSE:LUPIN
EPS (Diluted)
â‚ą57
CAGR 3-Years
N/A
CAGR 5-Years
53%
CAGR 10-Years
1%
M
Mankind Pharma Ltd
NSE:MANKIND
EPS (Diluted)
â‚ą47
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Torrent Pharmaceuticals Ltd
Glance View

Market Cap
1.2T INR
Industry
Pharmaceuticals
Economic Moat
Narrow

In the bustling realm of Indian pharmaceuticals, Torrent Pharmaceuticals Ltd. has carved out a notable niche, emerging from the industrious land of Gujarat. Founded in 1959, this company has transformed from a modest player to a major force in the industry, traversing the complexities of pharmaceutical manufacturing and global distribution. At its core, Torrent Pharmaceuticals is driven by a commitment to healthcare innovation and therapeutic excellence. The company systematically engages in developing, manufacturing, and marketing a wide array of generic pharmaceutical products primarily targeting cardiovascular, central nervous system, gastro-intestinal, anti-infective, and anti-diabetic therapeutic categories. This diverse product portfolio positions Torrent not just as a provider of remedies but as a critical player in improving health outcomes across numerous demographics and geographies. Torrent Pharmaceuticals operates on a robust business model that effectively integrates research, development, and widespread distribution to generate revenue. The company channels significant resources into its R&D capabilities, perpetually expanding its pipeline to introduce more effective and affordable medications. This ongoing innovation supports their competitive edge while fortifying their catalog of offerings. Additionally, Torrent's strategic alliances and acquisitions—most notably, the key acquisition of Elder Pharmaceuticals' branded domestic formulations business in India—have further catapulted its market presence both domestically and internationally. By leveraging its extensive marketing network and manufacturing capabilities compliant with international standards, Torrent not only bankrolls its growth through product sales but also ensures global reach, cementing its role as a pivotal component of the healthcare landscape.

TORNTPHARM Intrinsic Value
1 989.4 INR
Overvaluation 41%
Intrinsic Value
Price
T

See Also

What is Torrent Pharmaceuticals Ltd's EPS (Diluted)?
EPS (Diluted)
53.2 INR

Based on the financial report for Sep 30, 2024, Torrent Pharmaceuticals Ltd's EPS (Diluted) amounts to 53.2 INR.

What is Torrent Pharmaceuticals Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
8%

Over the last year, the EPS (Diluted) growth was 34%. The average annual EPS (Diluted) growth rates for Torrent Pharmaceuticals Ltd have been 12% over the past three years , 26% over the past five years , and 8% over the past ten years .

Back to Top